Home / Haloperidol / United States
US ATC N05AD01 · updated 2 Nov 2026
Haloperidol shortage in United States
Is there a Haloperidol shortage in United States?
Yes. As of 2 Nov 2026, 2 Haloperidol products are reported short in United States, the first since 9 Jan 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01) discontinuation | Fresenius Kabi USA, LLC | 9 Jan 2026 | not given | Not stated |
| US | Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05) discontinuation | Fresenius Kabi USA, LLC | 9 Jan 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).